دورية أكاديمية
Insurance Companies Fighting the Peer Review Empire without any Validity: the Case for Addiction and Pain Modalities in the face of an American Drug Epidemic.
| العنوان: | Insurance Companies Fighting the Peer Review Empire without any Validity: the Case for Addiction and Pain Modalities in the face of an American Drug Epidemic. |
|---|---|
| المؤلفون: | Blum K; Department of Psychiatry and Behavioral Sciences, Keck Medicine University of Southern California, USA.; Division of Applied Clinical Research & Education, Dominion Diagnostics, USA.; Department of Precision Medicine, Geneus Health LLC, USA.; Department of Clinical Neurology, Path Foundation, USA.; Institute of Psychology, Eötvös Loránd University, Hungary.; National Human Genome Center at Howard University, USA.; Department of Psychiatry, University of Vermont, School of Medicine, USA.; Department of Psychiatry, Boonshoft School of Medicine, Dayton VA Medical Center, Wright State University, US.; Department of Psychiatry, McKnight Brain Institute, University of Florida College of Medicine, USA.; Division of Neuroscience and Addiction Research & Therapy, Summit Estate Recovery Center, USA., Jacobs W; Department of Psychiatry and Health Behavior at the Medical College of Georgia at Georgia Regents University USA., Modestino EJ; Department of Psychology, Curry College, Milton, USA., DiNubile N; Department of Orthopedic Surgery, University of Pennsylvania School of Medicine, Philadelphia, USA., Baron D; Department of Psychiatry and Behavioral Sciences, Keck Medicine University of Southern California, USA., McLaughlin T; Center for Psychiatric Medicine, Lawrence, USA., Siwicki D; Department of Precision Medicine, Geneus Health LLC, USA., Elman I; Department of Psychiatry, Boonshoft School of Medicine, Dayton VA Medical Center, Wright State University, US., Moran M; Department of Precision Medicine, Geneus Health LLC, USA.; Consultants in Pain Management, San Antonio, USA., Braverman ER; Department of Clinical Neurology, Path Foundation, USA., Thanos PK; Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions, Research Institute on Addictions, University at Buffalo, USA., Badgaiyan RD; Department of Psychiatry, Icahn School of Medicine, USA. |
| المصدر: | SEJ surgery and pain [SEJ Surg Pain] 2018 Oct 04; Vol. 1 (1), pp. 1-11. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Scientific Exhalters Pvt. Ltd Country of Publication: India NLM ID: 101726601 Publication Model: Print Cited Medium: Internet NLM ISO Abbreviation: SEJ Surg Pain Subsets: PubMed not MEDLINE |
| أسماء مطبوعة: | Original Publication: Visakhapatnam, India : Scientific Exhalters Pvt. Ltd. |
| مستخلص: | The United States are amid an opioid overdose epidemic; we are challenged to provide non-addicting/non-pharmacological alternatives to assist in pain attenuation. There are proven strategies available to manage chronic pain effectively without opioids. Utilization review providers for insurance companies often ignore medicine based scientific peer-reviewed studies that warn against the chronic use of opioid medications, as well as the lack of evidence to support long-term use of opioids for pain. This paradigm must change if we are to indeed change the drug-embracing culture in American chronic pain management. A barrier to treatment is pushback on the part of insurance companies especially as it relates to fighting against pain relief alternatives compared to classical analgesic agents. Pain specialists in the U.S., are compelled to find alternative solutions to help pain victims without promoting unwanted tolerance to analgesics and subsequent biological induction of the "addictive brain." It is noteworthy that reward center of the brain plays a crucial role in the modulation of nociception, and that adaptations in dopaminergic circuitry may affect several sensory and affective components of chronic pain syndromes. Possibly knowing a patient's genetic addiction risk score (GARS™) could eliminate guessing as it relates to becoming addicted. Competing Interests: Conflict of Interests K. Blum is 100% owner of Synaptamine Inc. holding a number of nutrigenomic patents worldwide including Geneus Health holding genetic testing for RDS. All other authors have no conflict of interest to report. |
| References: | Neuropharmacology. 2014 Jan;76 Pt B:259-68. (PMID: 23643695) Health Aff (Millwood). 2016 Jun 1;35(6):1045-51. (PMID: 27269021) Neurosurg Clin N Am. 2014 Oct;25(4):763-75. (PMID: 25240663) Subst Use Misuse. 2018 Jan 28;53(2):220-229. (PMID: 29257919) Precis Med (Bangalore). 2017;2(1):17-22. (PMID: 29372187) Osteoarthritis Cartilage. 2016 Jun;24(6):962-72. (PMID: 26844640) Prev Med. 2015 Nov;80:10-1. (PMID: 25869219) Expert Opin Biol Ther. 2015 Jul;15(7):973-85. (PMID: 25974314) Nature. 2016 Feb 11;530(7589):148-51. (PMID: 26863966) J Orthop Res. 2009 Sep;27(9):1248-51. (PMID: 19204915) PLoS One. 2015 Aug 14;10(8):e0135957. (PMID: 26274819) Diabetes Care. 1997 Nov;20(11):1702-5. (PMID: 9353612) Pharmacol Ther. 2013 Dec;140(3):267-79. (PMID: 23872493) BMC Med. 2014 Oct 22;12:200. (PMID: 25604462) Prog Brain Res. 2016;224:155-73. (PMID: 26822358) Scientometrics. 2017;113(1):533-546. (PMID: 29056789) BMC Musculoskelet Disord. 2009 Oct 29;10 :132. (PMID: 19874593) Adv Ther. 2008 Jul;25(7):644-57. (PMID: 18636234) Philos Trans R Soc Lond B Biol Sci. 2016 Nov 19;371(1708):. (PMID: 28080961) N Engl J Med. 2017 Jun 1;376(22):2194-2195. (PMID: 28564561) Neurosci Lett. 1996 Aug 23;214(2-3):131-4. (PMID: 8878101) Front Biosci (Elite Ed). 2018 Jan 1;10 :175-196. (PMID: 28930612) J Pain Palliat Care Pharmacother. 2016 Jun;30(2):138-40. (PMID: 27301691) Am J Public Health. 2014 Aug;104(8):e32-42. (PMID: 24922138) Adv Ther. 2008 Sep;25(9):894-913. (PMID: 18781289) Postgrad Med. 2015 Mar;127(2):232-41. (PMID: 25526228) Asian J Surg. 2009 Oct;32(4):240-6. (PMID: 19892628) Austin Addict Sci. 2016;1(2):. (PMID: 27840857) J R Soc Med. 1996 Jul;89(7):396-400. (PMID: 8774539) Experientia. 1985 Jul 15;41(7):932-3. (PMID: 4007131) Adv Ther. 2006 Sep-Oct;23(5):739-49. (PMID: 17142209) Brain Res. 2011 Jul 21;1402:46-53. (PMID: 21669407) PLoS One. 2013 Jul 09;8(7):e69043. (PMID: 23874860) Angew Chem Int Ed Engl. 2008;47(38):7173-8. (PMID: 18655211) J Subst Abuse Treat. 2014 Feb;46(2):158-64. (PMID: 24074851) Cases J. 2010 Feb 10;3:54. (PMID: 20181141) Am J Health Syst Pharm. 2016 Jan 1;73(1):e1-2. (PMID: 26683672) Adv Ther. 2006 May-Jun;23(3):446-55. (PMID: 16912027) Mayo Clin Proc. 2018 Mar;93(3):344-350. (PMID: 29502564) Pharmacol Biochem Behav. 2002 Nov;73(4):821-8. (PMID: 12213527) Precis Med (Bangalore). 2016;1(1):18-33. (PMID: 28066828) Neuropharmacology. 2014 Sep;84:79-89. (PMID: 24012656) Clin Neurophysiol. 2006 May;117(5):972-8. (PMID: 16516541) Neuroscience. 2016 Dec 3;338:81-92. (PMID: 27189881) Neurosci Lett. 2013 Apr 29;541:258-62. (PMID: 23510745) J Med Genet. 2005 Jul;42(7):583-7. (PMID: 15994880) J Am Acad Dermatol. 2008 Apr;58(4):632-5. (PMID: 18249470) J Psychoactive Drugs. 1997 Apr-Jun;29(2):155-60. (PMID: 9250942) J Popul Ther Clin Pharmacol. 2012;19(2):e328-33. (PMID: 22885272) Br J Pharmacol. 2008 May;154(2):384-96. (PMID: 18414400) PLoS One. 2017 Apr 26;12 (4):e0174774. (PMID: 28445527) Med Hypotheses. 2005;64(5):1066-7. (PMID: 15780518) JAMA. 2017 Mar 21;317(11):1117-1118. (PMID: 28241189) J Reward Defic Syndr. 2015;1(2):75-80. (PMID: 27617300) JAMA. 1990 Apr 18;263(15):2055-60. (PMID: 1969501) Phys Sportsmed. 2008 Dec;36(1):103-14. (PMID: 20048478) Postgrad Med. 2010 Nov;122(6):214-26. (PMID: 21084796) J Reward Defic Syndr. 2015 Oct 21;1(3):87-94. (PMID: 26835513) |
| معلومات مُعتمدة: | R01 DA035923 United States DA NIDA NIH HHS; R01 NS073884 United States NS NINDS NIH HHS; R41 MD012318 United States MD NIMHD NIH HHS; I01 CX000479 United States CX CSRD VA; R21 MH073624 United States MH NIMH NIH HHS; I01 CX001118 United States CX CSRD VA; R01 DA035949 United States DA NIDA NIH HHS |
| فهرسة مساهمة: | Keywords: Addiction; Evidence-based medicine; Genetic addiction risk score GARSTM; Opioid epidemic |
| تواريخ الأحداث: | Date Created: 20180619 Latest Revision: 20200930 |
| رمز التحديث: | 20240628 |
| مُعرف محوري في PubMed: | PMC5998670 |
| PMID: | 29911684 |
| قاعدة البيانات: | MEDLINE |
| الوصف غير متاح. |